Phibro Animal Health (PAHC) Tops Q3 EPS by 2c, provides guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.31, $0.02 better than the analyst estimate of $0.29. Revenue for the quarter came in at $263.2 million versus the consensus estimate of $251.16 million.

GUIDANCE:

Phibro Animal Health sees FY2024 EPS of $1.04-$1.16, versus the consensus of $1.10.
Phibro Animal Health sees FY2024 revenue of $980-1.02 billion, versus the consensus of $997.7 million.
Adjusted EBITDA of $106 million to $112 million
Adjusted net income of $42 million to $47 million

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold